Keywords: positive, outcome, pozen, pa, poc, study, north
Positive outcome for Pozen's PA 325 PoC study
Article | 12 March 2007
North Carolina, USA- based Pozen has announced positive top-line results of its "Safer Aspirin" PA 325 proof-of-concept study conducted during the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
